Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...

Patients with antiphospholipid antibodies (aPL) are at increased risk for arterial or venous thrombosis. There is, however, significant heterogeneity among patients according to clinical and ...

Should Aspirin Be Used With Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure? Myung H. Park, MD Disclosures CHF. 2003;9 (4) 0 ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. All FDA-approved migraine treatments are approved only for adults. No migraine products have officially been approved for use in children. Other types ...

MINNEAPOLIS — Universal presumption of low-dose aspirin, instead of risk-based screenings, can increase uptake for preeclampsia prevention in underserved populations, according to a speaker at ...

Although urine 11-dTXB2 did not significantly decrease with aspirin therapy in patients with HAPR, Fontan patients without HAPR demonstrated a significant 50% median decrease in urine 11-dTXB2 from ...

The daily use of low-dose aspirin against heart disease may have taken another knock. New research shows that the practice may not provide the added benefit of reduced heart attack risk to Black ...

High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects the long-term course ...

Liverpool are continuing to pursue a move for Bayer Leverkusen midfielder Florian Wirtz. The Reds have identified the playmaker as one of their key targets for the summer transfer window and remain in ...

Objective This review aims to analyse strength training-based sports injury prevention randomised controlled trials (RCT) and present best evidence recommendations for athletes and future research. A ...

Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS Berlin Tuesday, June 3, 2025, 13:00 Hrs [IST] Bayer ...